Showing results (11-20 of 22) with videos related to

Sort By:
Pageof 3
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 19, 2019
Discovery, Validation, and Application of Novel Methylated DNA Markers for Detection of Esophageal Cancer in PlasmaYi Qin, Chung W Wu, William R Taylor, et al.
Life (Basel, Switzerland)|August 29, 2024
Methylated DNA Markers in Voided Urine for the Identification of Clinically Significant Prostate CancerParas Shah, William R Taylor, Brianna J Negaard, et al.
JCO Precision Oncology|October 26, 2023
Plasma Methylated DNA Markers for Melanoma SurveillanceCalise K Berger, William R Taylor, Douglas W Mahoney, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 8, 2020
Novel Methylated DNA Markers in the Surveillance of Colorectal Cancer RecurrenceHao Xie, Douglas W Mahoney, Patrick H Foote, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 17, 2021
High Detection Rates of Pancreatic Cancer Across Stages by Plasma Assay of Novel Methylated DNA Markers and CA19-9Shounak Majumder, William R Taylor, Patrick H Foote, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 31, 2018
Detection of Gastric Cancer with Novel Methylated DNA Markers: Discovery, Tissue Validation, and Pilot Testing in PlasmaBradley W Anderson, Yun-Suhk Suh, Boram Choi, et al.
NPJ Breast Cancer|November 29, 2025
Plasma assay of methylated DNA markers detects recurrent metastatic breast cancerKarthik V Giridhar, Jason P Sinnwell, Seth W Slettedahl, et al.
American Journal of Hematology|November 20, 2024
Blood Plasma Methylated DNA Markers in the Detection of Lymphoma: Discovery, Validation, and Clinical PilotThomas E Witzig, William R Taylor, Douglas W Mahoney, et al.
Hepatology (Baltimore, Md.)|September 1, 2018
Hepatocellular Carcinoma Detection by Plasma Methylated DNA: Discovery, Phase I Pilot, and Phase II Clinical ValidationJohn B Kisiel, Brian A Dukek, Reddappa V S R Kanipakam, et al.
Gynecologic Oncology|April 4, 2022
Methylated DNA markers for plasma detection of ovarian cancer: Discovery, validation, and clinical feasibilityLisa M Marinelli, John B Kisiel, Seth W Slettedahl, et al.
Pageof 3